Emerging Clinical Issues in Novel Treatment Modalities - Video Series

Thank you for accessing the “Emerging Clinical Issues in Novel Treatment Modalities” video series!

This four-part series was designed to meet the current educational needs of prescribers faced with an increasingly complex and ever-evolving hemophilia treatment landscape with particular focus on the ‘non-factor’ products currently approved by the U.S. Food and Drug Administration as well as emerging novel therapies still in development.

We would be delighted to receive your feedback!

*1.I watched the following video(Required.)

"Understanding Mechanisms of Action and Utility of Novel Treatments for Hemophilia A and B”

“Shared Decision Making in the Age of Novel Technologies for Hemophilia”

“Managing Complex Cases with Novel Non-Factor Therapies"

"Navigating Reimbursement for Patients on Non-Factor Therapy”

*2.I am(Required.)

Someone who prescribes therapies for patients with bleeding disorders

Someone who works with patients at a hemophilia treatment center (HTC)

A healthcare professional working outside the HTC network

Someone who does not treat patients with bleeding disorders

An individual or family member affected by a bleeding disorder

*3.My knowledge of non-factor therapies was increased after watching this webinar activity.(Required.)

Agree

Disagree

*4.My ability to make appropriate treatment decisions with patients on the use of non-factor products has been enhanced after watching this webinar.(Required.)

Agree

Disagree

not applicable - I do not see patients

5.Do you have any general comments to share regarding this particular learning activity and/or the overall program?

See how easy it is to create surveys and forms.

Privacy & Cookie Notice